REAL-WORLD STUDY ON VEDOLIZUMAB EFFICACY AND SAFETY AFTER THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS

Vlasta Orsic Fric  ^{1, 2}     Vladimir Borzan  ^{1, 2}     Ines Šahinović  ^{1, 2}     Andrej Borzan  ²     Marija Tripolski  ²     Sven Kurbel  ^2    
1 University Hospital Center Osijek, Osijek, Croatia
² Faculty of Medicine, J. J. Strossmayer University of Osijek, Osijek, Croatia

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)